drugset / Trial / NCT00369018

A Dose-finding Study of MAL and HAL Photodynamic Therapy of Cervical Premalignant Lesions.

NCT00369018

Phase 1/2 Completed 96 enrolled Photocure
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The study will determine the best drug (MAL or HAL) dosage for photodynamic therapy of cervical precancerous lesions (dysplasia) in women that are referred for conisation (surgery).

Timeline

Start
2006-08
Primary completion
2009-07
Completion
2009-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator hexaminolevulinate Small molecule 10 unknown Topical
Comparator hexaminolevulinate Small molecule 40 unknown Topical
Comparator methyl aminolevulinate Small molecule 1.2 unknown Topical

Indications